tradingkey.logo

Meihua International Medical Technologies Co Ltd

MHUA
7.610USD
0.000
收盘 12/24, 13:00美东报价延迟15分钟
2.41M总市值
0.25市盈率 TTM

Meihua International Medical Technologies Co Ltd

7.610
0.000

关于 Meihua International Medical Technologies Co Ltd 公司

Meihua International Medical Technologies Co Ltd is a holding company mainly engaged in the research, development, manufacturing and sales of Class I, Class II and Class III disposable medical devices. The Company's products include self-manufactured and out-sourced products. Class I disposable medical devices include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene (LDPE) bottles for eye drops, high-density polyethylene (HDPE) bottles for tablets, and others. Class II disposable medical devices include disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, and others. Class III disposable medical devices include disposable infusion pumps, anesthesia puncture kits, electronic pumps, and others.

Meihua International Medical Technologies Co Ltd简介

公司代码MHUA
公司名称Meihua International Medical Technologies Co Ltd
上市日期Feb 16, 2022
CEOWang (Yulin)
员工数量619
证券类型Ordinary Share
年结日Feb 16
公司地址88 Tongda Road, Touqiao Town, Guangling District
城市YANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编225000
电话8651489800199
网址https://meihuamed.com/
公司代码MHUA
上市日期Feb 16, 2022
CEOWang (Yulin)

Meihua International Medical Technologies Co Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
159.35K
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
159.35K
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Liu (Yongjun)
22.83%
XTX Markets LLC
0.05%
Renaissance Technologies LLC
0.04%
Marex Group plc
0.04%
Citadel Advisors LLC
0.03%
其他
77.01%
持股股东
持股股东
占比
Liu (Yongjun)
22.83%
XTX Markets LLC
0.05%
Renaissance Technologies LLC
0.04%
Marex Group plc
0.04%
Citadel Advisors LLC
0.03%
其他
77.01%
股东类型
持股股东
占比
Individual Investor
28.50%
Hedge Fund
0.10%
Venture Capital
0.06%
Investment Advisor
0.04%
Investment Advisor/Hedge Fund
0.02%
其他
71.28%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
15
164.61K
0.52%
-2.53M
2025Q2
14
16.27M
51.01%
-2.20M
2025Q1
18
16.27M
51.01%
-2.22M
2024Q4
19
16.19M
50.75%
-2.28M
2024Q3
18
18.39M
58.65%
+1.61M
2024Q2
17
16.65M
52.69%
+166.88K
2024Q1
18
16.39M
51.82%
+107.48K
2023Q4
16
16.23M
51.17%
+182.79K
2023Q3
13
15.99M
66.79%
-24.95K
2023Q2
13
15.96M
66.67%
-82.11K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Liu (Yongjun)
15.94M
49.95%
--
--
Dec 31, 2024
XTX Markets LLC
--
0%
-19.00K
-100.00%
Jun 30, 2025
Renaissance Technologies LLC
24.10K
0.08%
+11.70K
+94.35%
Jun 30, 2025
Marex Group plc
16.21K
0.05%
+16.21K
--
Jun 30, 2025
Citadel Advisors LLC
--
0%
-150.52K
-100.00%
Jun 30, 2025
Geode Capital Management, L.L.C.
14.39K
0.05%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
93.66K
0.29%
+7.38K
+8.56%
Jun 30, 2025
Two Sigma Investments, LP
16.25K
0.05%
-11.58K
-41.61%
Jun 30, 2025
Virtu Americas LLC
--
0%
-41.36K
-100.00%
Mar 31, 2025
HRT Financial LP
--
0%
-33.44K
-100.00%
Mar 31, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Meihua International Medical Technologies Co Ltd的前五大股东是谁?

Meihua International Medical Technologies Co Ltd 的前五大股东如下:
Liu (Yongjun)持有股份:15.94M,占总股份比例:49.95%。
XTX Markets LLC持有股份:0.00,占总股份比例:0.00%。
Renaissance Technologies LLC持有股份:24.10K,占总股份比例:0.08%。
Marex Group plc持有股份:16.21K,占总股份比例:0.05%。
Citadel Advisors LLC持有股份:0.00,占总股份比例:0.00%。

Meihua International Medical Technologies Co Ltd的前三大股东类型是什么?

Meihua International Medical Technologies Co Ltd 的前三大股东类型分别是:
Liu (Yongjun)
XTX Markets LLC
Renaissance Technologies LLC

有多少机构持有Meihua International Medical Technologies Co Ltd(MHUA)的股份?

截至2025Q3,共有15家机构持有Meihua International Medical Technologies Co Ltd的股份,合计持有的股份价值约为164.61K,占公司总股份的0.52%。与2025Q2相比,机构持股有所增加,增幅为-50.49%。

哪个业务部门对Meihua International Medical Technologies Co Ltd的收入贡献最大?

在FY2024,Resales of Sourced Disposable Medical Devices from Third Party Manufacturers业务部门对Meihua International Medical Technologies Co Ltd的收入贡献最大,创收49.30M,占总收入的50.88%。
KeyAI